Patent details

EP2152754 Title: MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2152754
WO Application Number:
EP2008004197
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP08758782.0
WO Publication Number:
WO2008145338
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Germany (DE)
Publications:

Dates

Filing date:
27/05/2008
Grant date:
25/04/2018
EP Publication Date:
17/02/2010
WO Publication Date:
04/12/2008
Claims Translations Received Date:
Claims Translation B1 Received Date:
05/07/2018
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
25/04/2018
EP B1 Publication Date:
25/04/2018
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
26/05/2028
Lapsed By Expiration Date:
Patent Validated Date:
26/07/2018
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
04/07/2018
 
 

 

Name:
Astellas Pharma Inc.
Address:
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, 103-8411, Tokyo, Japan (JP)

From:
04/07/2018
 
 

 

Name:
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH
Address:
Freiligrathstrasse 12, 55131, Mainz, Germany (DE)

Historical Applicant/holder

From:
25/04/2018
To:
04/07/2018

 

Name:
Ganymed Pharmaceuticals GmbH
Address:
An der Goldgrube 12, 55131 MAINZ, Germany (DE)

From:
25/04/2018
To:
04/07/2018

 

Name:
Johannes-Gutenberg-Universität Mainz
Address:
Saarstrasse 21, 55122 MAINZ, Germany (DE)

Agent

Name:
dr. A. Krebs
From:
25/07/2018
Address:
HGF B.V. Benoordenhoutseweg 46, 2596 BC, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
SAHIN, Ugur
Address:
55116 Mainz, Germany (DE)

2

Name:
TÜRECI, Özlem
Address:
55116 Mainz, Germany (DE)

3

Name:
BRANDENBURG, Gunda
Address:
22880 Wedel, Germany (DE)

4

Name:
USENER, Dirk
Address:
65193 Wiesbaden, Germany (DE)

Priority

1

Priority Patent Number:
932099 P
Priority Date:
29/05/2007
Priority Country:
United States of America (US)

2

Priority Patent Number:
07010622
Priority Date:
29/05/2007
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
A61K 39/395; A61P 35/00; C07K 16/30; C12N 5/12;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
38/18
Publication date:
12/09/2018
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP3
Journal edition number:
32/18
Publication date:
01/08/2018
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
18/18
Publication date:
25/04/2018
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201827
Publication date:
04/07/2018
Description:
Document reprinted after correction (B8, B9)

2

Issue number:
201822
Publication date:
30/05/2018
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
201817
Publication date:
25/04/2018
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201801332A
Date Registered:
04/07/2018
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. A. Krebs
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH
Address:
Freiligrathstrasse 12, 55131, Mainz, Germany (DE)

2

Name:
Astellas Pharma Inc.
Address:
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, 103-8411, Tokyo, Japan (JP)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/05/2025
Annual Fee Number:
18
Annual Fee Amount:
1200 Euro
Last Annual Payment Date:
26/05/2024
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
1100 Euro
Payer:
Computer Packages Inc. (CPI)
Filing date Document type Document Description Number of pages File Type
07/09/2018 Outgoing Correspondence Letter registration deed 1 PDF /0/8/7/2/6/0800262780/docs/ep08758782.0_4_227067l118.pdf
25/07/2018 Outgoing Correspondence Letter no formal defects 1 PDF /0/8/7/2/6/0800262780/docs/ep08758782.0_5_219603l271.pdf
05/07/2018 Incoming Correspondence Electronic EOB model 2 PDF /0/8/7/2/6/0800262780/docs/ep08758782.0_0_incomingcorrespondenceelectronic20180705143905353.pdf
05/07/2018 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /0/8/7/2/6/0800262780/docs/ep08758782.0_1_incomingcorrespondenceelectronic20180705143903170.pdf
05/07/2018 Claims First filed claims 6 PDF /0/8/7/2/6/0800262780/docs/ep08758782.0_2_claims20180705143902430.pdf
05/07/2018 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /0/8/7/2/6/0800262780/docs/ep08758782.0_6_incomingcorrespondenceelectronic20180705143906276.pdf
05/07/2018 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /0/8/7/2/6/0800262780/docs/ep08758782.0_7_incomingcorrespondenceelectronic20180705143904232.pdf
04/07/2018 Request for Change First filed deed 6 PDF /0/8/7/2/6/0800262780/docs/ep08758782.0_3_rfc20180727090121984.pdf